<div id="readability-page-1">Looking for top-rated stocks to buy now? Recent analyst updates highlight three companies that have earned Strong Buy ratings from Top Wall Street analysts. Each stock offers solid upside potential, supported by fresh Buy calls.<h3>Claim 70% Off TipRanks This Holiday Season</h3><ul><li>Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions </li><li> Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential</li></ul> For more stock ideas, check out TipRanks' Analyst Top Stocks tool, which tracks the latest Buy ratings from top analysts in real time. Here are today's top analyst-backed stock picks. Click on any ticker to research the company before deciding whether to add it to your portfolio. CG Oncology (CGON) – This is a clinical-stage biotechnology company focused on developing immunotherapy treatments for bladder cancer. Yesterday, LifeSci Capital analyst Sam Slutsky maintained a Buy rating on the stock with a price target of $90 per share. In the last three months, all nine Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 81.79%. WhiteFiber (WYFI) – This is a communications infrastructure company that builds and operates fiber-optic networks to support broadband and data connectivity services. Yesterday, H.C. Wainwright analyst Kevin Dede maintained a Buy rating on the stock with a price target of $34 per share. In the last three months, all seven Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 92.74%. Arcellx (ACLX) – Arcellx is a clinical-stage biotech firm that develops cell therapies to treat cancer, with a main focus on blood cancers like multiple myeloma. Yesterday, Wells Fargo analyst Yanan Zhu initiated coverage on the stock with a price target of $100 per share. In the last three months, all 42 Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 30.75%. <h2>Who Are the Top Analysts? </h2> TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks' Top Wall Street Analysts page. </div>

ACLX

CGON

WYFI

Top Wall Street analysts have given Strong Buy ratings to three stocks: CG Oncology (CGON), WhiteFiber (WYFI), and Arcellx (ACLX). CGON has a price target of $90 with an 81.79% upside, WYFI has a price target of $34 with a 92.74% upside, and ACLX has a price target of $100 with a 30.75% upside. All analysts covering these stocks have rated them as Buys in the last three months.

- Analysts have identified three top-rated stocks: CG Oncology (CGON), WhiteFiber (WYFI), and Arcellx (ACLX), all with Strong Buy ratings.  
- CG Oncology has an upside potential of approximately 81.79%, WhiteFiber at 92.74%, and Arcellx at 30.75% based on analyst price targets.  
- The recommendations come from successful analysts ranked by TipRanks, which provides insights into stock performance and analyst profitability.

3 'Strong Buy' Stocks to Buy Today,12/23/2025, According to Top Analysts